BAGSVÆRD, DENMARK – The World Diabetes Foundation today announces the constitution of a new Board of Directors. The Board consists of Dr Anil Kapur (Chair), Ms Camilla Sylvest (Vice-chair), Ms Ida Nicolaisen, Dr Kaushik Ramaiya, Prof Abdallah Daar, and Mr Frederik Kier.
Ms Camilla Sylvest is Executive vice president, Commercial Strategy & Corporate Affairs at Novo Nordisk A/S, and based in Copenhagen, Denmark. She joined the company in 1996, and in 2003 was appointed vice president of sales and marketing effectiveness in Region Europe. From 2008 to 2015, Ms Sylvest headed up affiliates and business areas in Europe and Asia, and in August 2015 she was appointed senior vice president and general manager of Novo Nordisk’s Region China. In October 2017, Ms Sylvest was promoted to executive vice president and member of Executive Management in Novo Nordisk.
Ms Sylvest holds an MSc in Economics from University of Southern Denmark and an Executive MBA from Scandinavian International Management Institute.
Ms Sylvest assumes the vice chair post from Ms Michala Fischer-Hansen, who left the Board in July upon her departure from Novo Nordisk.
The World Diabetes Foundation is an independent trust dedicated to the prevention and treatment of diabetes in the developing world.
Its aim is to alleviate human suffering related to diabetes and its complications among those least able to withstand the burden of the disease. The Foundation supports sustainable partnerships and acts as a catalyst to help others do more.
From 2002 to 2018, the World Diabetes Foundation provided 148 million USD in funding to 555 partnership projects in 116 countries, focusing on awareness, education and capacity building at the local, regional and global level. For every dollar spent, the Foundation is able to raise approximately 2 dollars in cash or as in-kind donations from other sources.
For more information, please visit www.worlddiabetesfoundation.org
World Diabetes Foundation
Phone: + 45 30 79 43 09